Fig. 3From: Efficacy and safety of lenvatinib monotreatment and lenvatinib-based combination therapy for patients with unresectable hepatocellular carcinoma: a retrospective, real-world study in ChinaRepresentative images of liver tumor size in patients before and after lenvatinib treatment. A A CT image of a male patient before lenvatinib monotreatment (left) and 23 months after lenvatinib treatment (right). B A CT image of a female patient before treatment (left) and 4 months after lenvatinib + PD1 + HAIF treatment (right)Back to article page